The company provides a complete product portfolio for extrapulmonary lung assist and combines cardiac and pulmonary support on one single platform, which allows physicians to treat critically ill patients with more vital treatment time during diagnosis and therapy. XENiOS AG is part of Fresenius Medical Care, the world's leading provider of products and services for people with renal diseases, and complements their product portfolio in the field of intensive care. The company's mission is to improve patient well-being and care by developing intelligent technological solutions that can be vital for the survival of critically ill patients.